State Street’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $881K | Buy |
290,907
+207,707
| +250% | +$629K | ﹤0.01% | 3512 |
|
2025
Q1 | $354K | Buy |
83,200
+1,000
| +1% | +$4.26K | ﹤0.01% | 3683 |
|
2024
Q4 | $434K | Buy |
82,200
+55,600
| +209% | +$294K | ﹤0.01% | 3653 |
|
2024
Q3 | $48.7K | Hold |
26,600
| – | – | ﹤0.01% | 4108 |
|
2024
Q2 | $55.3K | Hold |
26,600
| – | – | ﹤0.01% | 4125 |
|
2024
Q1 | $107K | Sell |
26,600
-4,300
| -14% | -$17.2K | ﹤0.01% | 4021 |
|
2023
Q4 | $57.8K | Hold |
30,900
| – | – | ﹤0.01% | 4172 |
|
2023
Q3 | $51.6K | Hold |
30,900
| – | – | ﹤0.01% | 4281 |
|
2023
Q2 | $73.9K | Hold |
30,900
| – | – | ﹤0.01% | 4303 |
|
2023
Q1 | $95.8K | Hold |
30,900
| – | – | ﹤0.01% | 4338 |
|
2022
Q4 | $82.8K | Hold |
30,900
| – | – | ﹤0.01% | 4427 |
|
2022
Q3 | $91K | Hold |
30,900
| – | – | ﹤0.01% | 4495 |
|
2022
Q2 | $91K | Hold |
30,900
| – | – | ﹤0.01% | 4565 |
|
2022
Q1 | $158K | Buy |
30,900
+1,100
| +4% | +$5.63K | ﹤0.01% | 4471 |
|
2021
Q4 | $201K | Buy |
29,800
+7,000
| +31% | +$47.2K | ﹤0.01% | 4351 |
|
2021
Q3 | $158K | Buy |
22,800
+12,441
| +120% | +$86.2K | ﹤0.01% | 4431 |
|
2021
Q2 | $101K | Sell |
10,359
-49,774
| -83% | -$485K | ﹤0.01% | 4365 |
|
2021
Q1 | $946K | Buy |
60,133
+10,100
| +20% | +$159K | ﹤0.01% | 3632 |
|
2020
Q4 | $1.21M | Buy |
50,033
+27,015
| +117% | +$654K | ﹤0.01% | 3526 |
|
2020
Q3 | $387K | Buy |
23,018
+4,861
| +27% | +$81.7K | ﹤0.01% | 3599 |
|
2020
Q2 | $532K | Buy |
+18,157
| New | +$532K | ﹤0.01% | 3535 |
|
2016
Q2 | – | Sell |
-2,361
| Closed | -$729K | – | 3762 |
|
2016
Q1 | $729K | Buy |
2,361
+874
| +59% | +$270K | ﹤0.01% | 3285 |
|
2015
Q4 | $924K | Buy |
1,487
+123
| +9% | +$76.4K | ﹤0.01% | 3223 |
|
2015
Q3 | $758K | Buy |
1,364
+183
| +15% | +$102K | ﹤0.01% | 3260 |
|
2015
Q2 | $844K | Buy |
+1,181
| New | +$844K | ﹤0.01% | 3280 |
|